Non-coding RNA RsaE regulates biofilm thickness, viability and dissemination in methicillin-resistant Staphylococcus aureus

This study identifies the non-coding RNA RsaE as a critical regulator in MRSA that, in conjunction with RNase Y, fine-tunes phenol-soluble modulin (PSM) expression through post-transcriptional and transcriptional mechanisms, thereby controlling biofilm architecture, cell viability, and systemic dissemination during infection.

The Gist

The Big Picture: The "Tiny Manager" of a Bacterial City

Imagine Staphylococcus aureus (specifically the super-resistant MRSA kind) not as a single germ, but as a bustling, chaotic city. This city has two main jobs:

1. Build a fortress: They build thick, slimy walls called biofilms to protect themselves from antibiotics and the immune system.
2. Send out spies: They release tiny toxic weapons called PSM toxins to break down enemy cells (like your white blood cells) and help the bacteria spread to new places (like your kidneys).

The scientists in this paper discovered a tiny, invisible "manager" inside the bacteria called RsaE. Think of RsaE as a strict foreman or a traffic cop. Its job is to make sure the city doesn't get too rowdy, the fortress isn't too thin, and the spies aren't sent out at the wrong time.

The Discovery: What happens when the Manager is fired?

The researchers decided to see what happens if they "fire" this manager (by deleting the rsaE gene). Here is what they found:

1. The "Toxic Weapon" Factory Goes Wild

Normally, RsaE keeps the production of the toxic weapons (PSM toxins) in check. It acts like a dimmer switch, ensuring the lights aren't too bright.

• Without RsaE: The factory goes into overdrive. The bacteria start making way too many toxins.
• The Twist: Even though they are making more toxin instructions (RNA), the factory floor is messy. The instructions for some specific toxins are written in a way that is hard to read (they are folded up like origami). So, while the amount of instructions goes up, the bacteria still struggle to build the specific toxins efficiently. It's like having a library full of books, but the pages are glued together, so you can't read them all easily.

2. The Fortress (Biofilm) Gets Thin and Flimsy

Biofilms are like the city's castle walls. They need to be thick and sturdy to survive.

• Without RsaE: The walls become thinner and weaker. The "mortar" holding the bricks together (which is made of DNA and proteins) is missing.
• The Analogy: Imagine a brick wall where the cement is missing. The bricks (bacteria) might still be there, but the wall is fragile and easy to knock down.

3. The "Zombie" Effect (Survival vs. Spread)

This is the most surprising part.

• In the Lab (Petri Dish): When the manager is fired, the bacteria inside the thin walls actually seem healthier and live longer for a while. It's like the workers are partying because the strict boss is gone.
• In the Real World (Mouse Model): When the researchers put these bacteria into a mouse with a catheter (a tube that helps bacteria stick to the body), the story changed completely.
  • The "fired manager" bacteria built a weird, jelly-like mess instead of a solid wall.
  • Crucially: They failed to spread to the kidneys.
  • Why? Because the fortress was so poorly built, the bacteria got stuck. They couldn't break out of the biofilm to travel to other parts of the body. It's like a city that is so disorganized that its citizens can't leave the city limits to go on a mission.

The "How" and "Why" (The Mechanics)

The paper digs deep into how RsaE does this:

• The "Seed" Sequence: RsaE has a specific "key" (a sequence of letters in its code) that fits into the "lock" of the toxin instructions. If you break this key, the manager can't do its job, and the toxins go wild.
• The Double Agent: RsaE doesn't just stop the toxins directly. It also talks to the bacteria's "quorum sensing" system (a way bacteria talk to each other to decide when to attack). By messing with this conversation, RsaE indirectly tells the bacteria to turn up the toxin production, but in a way that creates a chaotic, unstable biofilm.

The Takeaway: Why should we care?

This research is a bit like finding a weak spot in a villain's armor.

1. Understanding the Enemy: We now know that RsaE is the glue holding the MRSA biofilm together and controlling its ability to spread.
2. New Treatments: If we can design a drug that mimics RsaE (or blocks the bacteria from ignoring it), we might be able to force the bacteria to build weak, thin biofilms.
3. Stopping the Spread: If the biofilm is weak, the bacteria can't spread from the infection site (like a catheter) to vital organs (like the kidneys). This could turn a life-threatening infection into a manageable one.

In short: The paper shows that a tiny piece of genetic code (RsaE) acts as the master architect and traffic controller for MRSA. Without it, the bacteria build a flimsy house and get stuck inside, unable to invade the rest of the body. This gives scientists a new target to hit to stop these superbugs from spreading.

Technical Summary

1. Problem Statement

Methicillin-resistant Staphylococcus aureus (MRSA) is a major global pathogen, particularly in device-associated infections where biofilms play a critical role in persistence and dissemination. A key virulence factor in MRSA is the $\alpha$-phenol-soluble modulin (PSM$\alpha$) operon, which encodes four cytolytic peptides (PSM$\alpha$1–4). These peptides drive biofilm maturation, immune evasion, and bacterial dissemination.

While the small non-coding RNA RsaE was previously identified as a potential regulator of the psm$\alpha$ operon via RNA-RNA interactions, its precise mechanism of action and its biological impact on biofilm architecture, cell viability, and in vivo infection outcomes remained unclear. Specifically, it was unknown how RsaE balances the expression of individual PSM$\alpha$ peptides (which have distinct functions) and how this regulation translates to infection dynamics.

2. Methodology

The study employed a multi-faceted approach combining molecular biology, structural biology, and in vivo infection models:

• Transcriptomics & Ribosome Profiling: RNA-seq and ribosome profiling (Ribo-seq) were performed on USA300 (clinical MRSA) and HG003 strains to assess transcript abundance and translation efficiency in wild-type (WT) versus $\Delta$rsaE mutants.
• RNA Stability & Structure:
  • Rifampicin Chase Assays: Used to determine the half-life of the psm$\alpha$ transcript in WT, $\Delta$rsaE, and $\Delta$rny (RNase Y) strains.
  • Northern Blotting: Validated transcript levels and sizes.
  • SHAPE-MaP (Selective 2'-Hydroxyl Acylation analyzed by Primer Extension and Mutational Profiling): Used in vivo chemical probing to map the secondary structure of the psm$\alpha$ transcript, specifically focusing on the accessibility of Shine-Dalgarno (SD) sequences.
• Genetic Manipulation:
  • Generation of deletion mutants ($\Delta$rsaE, $\Delta$rny, $\Delta$rnc, $\Delta$psm$\alpha$) in the USA300 background.
  • Complementation: Re-introduction of WT RsaE and seed-sequence mutants (mut-1, mut-2, mut-both) to identify the specific RNA motifs required for regulation.
• Biofilm Analysis:
  • In Vitro: Crystal violet (CV) assays for biomass; Confocal Laser Scanning Microscopy (CLSM) with multi-channel staining (Hoechst for DNA, SYPRO Ruby for proteins, WGA for polysaccharides, TOTO-3 for B-DNA, Z22 antibody for Z-DNA) to quantify thickness, cell counts, and extracellular DNA (eDNA) architecture.
  • Viability: Colony Forming Unit (CFU) counts over time to assess cell survival within biofilms.
• In Vivo Model: A murine catheter-associated biofilm infection model. Mice were implanted with catheters inoculated with WT or mutant strains. After 3 days, catheters and kidneys were harvested for CFU analysis (dissemination) and Scanning Electron Microscopy (SEM) to visualize biofilm structure.

3. Key Contributions & Results

*A. Mechanism of psm$\alpha$ Regulation*

• Transcriptional and Post-Transcriptional Control: RsaE and RNase Y act as negative regulators of psm$\alpha$. Deletion of rsaE or rny leads to a significant increase in psm$\alpha$ transcript levels.
• Transcriptional Activation via agr: The increase in psm$\alpha$ levels in $\Delta$rsaE is largely driven by the activation of the agr quorum-sensing system. While agr transcript levels remained unchanged, ribosome occupancy on agr mRNA increased significantly in the absence of RsaE, suggesting RsaE normally represses agr translation.
• Post-Transcriptional Stability: The psm$\alpha$ transcript is unusually stable (half-life ~15 min in WT). In $\Delta$rsaE and $\Delta$rny strains, the half-life increased to ~25–28 minutes, indicating RsaE and RNase Y promote transcript decay.
• Structural Basis for Differential Translation: SHAPE-MaP revealed the psm$\alpha$ transcript is highly structured.
  • The SD sequences of psm$\alpha$2 and psm$\alpha$3 are deeply sequestered in stem-loops, limiting ribosome access.
  • The SD sequence of psm$\alpha$4 is in a flexible region, favoring its translation.
  • Fine-Tuning: RsaE base-pairs with the SD of psm$\alpha$3. In $\Delta$rsaE, ribosome occupancy increased for psm$\alpha$1, 2, and 4, but *not for psm$\alpha$3*, confirming that intrinsic RNA structure dominates psm$\alpha$3 regulation, while RsaE provides fine-tuning.
• Seed Sequence Specificity: The 5' UCCCC motif of RsaE is necessary and sufficient for regulating psm$\alpha$ stability.

B. Impact on Biofilm Architecture and Viability

• Biofilm Thickness and eDNA: In vitro, $\Delta$rsaE biofilms were significantly thinner than WT. Crucially, the extracellular DNA (eDNA) layer was diminished and less organized in the mutant. The eDNA in WT biofilms forms a dense surface layer, whereas in $\Delta$rsaE, it is more evenly distributed and sparse.
• Cell Viability: Contrary to the reduced biomass, $\Delta$rsaE biofilms exhibited transiently elevated cell viability (higher CFUs) during early to mid-stages (8–48 hours). This is likely due to the derepression of TCA cycle enzymes, enhancing metabolic fitness in the absence of RsaE.
• RNase III Role: A surprising finding was that $\Delta$rnc (RNase III) mutants showed a severe defect in early biofilm formation, linking RNase III to biofilm establishment.

C. In Vivo Dissemination Phenotype

• Reduced Dissemination: In the murine catheter model, despite higher in vitro viability, $\Delta$rsaE bacteria showed significantly reduced dissemination to the kidneys compared to WT.
• Structural Abnormalities: SEM analysis revealed that in vivo $\Delta$rsaE biofilms had sparser bacterial colonization and a gelatinous matrix structure, distinct from the dense, clustered cocci seen in WT. This suggests that the structural integrity provided by RsaE-regulated PSMs and eDNA is essential for the bacteria to detach and spread from the device to systemic sites.

4. Significance

• Novel Regulatory Axis: The study identifies RsaE as a critical link connecting central metabolism (TCA cycle), quorum sensing (agr), and virulence factor expression (psm$\alpha$). It demonstrates that RsaE deletion paradoxically increases toxin transcript levels but disrupts the structural integrity required for infection spread.
• Mechanistic Insight into sRNA Function: It provides a rare example of an sRNA (RsaE) acting through a dual mechanism: direct base-pairing to fine-tune translation of specific operon members and indirect activation of the agr system via translational repression.
• Biofilm Complexity: The findings highlight that biofilm "biomass" (CV staining) does not always correlate with "viability" or "dissemination potential." A biofilm with higher cell viability but defective architecture (due to lack of RsaE) fails to disseminate effectively in vivo.
• Therapeutic Implications: Understanding how RsaE controls the balance between biofilm maturation and dissemination offers new targets for anti-virulence strategies. Disrupting RsaE function could potentially trap MRSA in a biofilm state that is metabolically active but unable to spread systemically, making it more susceptible to clearance.

Conclusion

RsaE is a master regulator in MRSA that ensures the optimal production of PSM$\alpha$ toxins and the proper structuring of the biofilm matrix. By repressing agr translation and promoting psm$\alpha$ transcript decay, RsaE prevents toxic overexpression while maintaining the structural integrity (specifically the eDNA layer) necessary for bacterial dissemination from medical devices. Its absence leads to a "hyper-viable" but structurally compromised biofilm that fails to spread in a host environment.